Search for: "AMGEN INC."
Results 261 - 280
of 704
Sort by Relevance
|
Sort by Date
8 Nov 2016, 8:23 pm
Amgen Inc. 16-332 Issues: (1) Whether the U.S. [read post]
13 Oct 2016, 6:50 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
25 Sep 2016, 7:00 am
Amgen Inc., IPR2016-01542, Paper 2, p.69), were introduced as previous publications of an expert witness in order to help prove their... [read post]
18 Sep 2016, 6:03 pm
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
5 Sep 2016, 6:46 pm
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
15 Aug 2016, 11:00 am
Both come from biotech pharmaceutical company Amgen Inc. [read post]
9 Aug 2016, 7:50 am
" Amgen Inc. et al v. [read post]
25 Jul 2016, 4:15 am
In Amgen Inc. v. [read post]
13 Jul 2016, 4:15 am
The Supreme Court is currently considering whether to review Amgen Inc. v. [read post]
11 Jul 2016, 9:59 pm
By Andrew Williams -- Last year, the Federal Circuit described the Biologics Price Competition and Innovation Act ("BPCIA") as "a riddle wrapped in a mystery inside of an enigma" in the Amgen v. [read post]
5 Jul 2016, 10:00 pm
Post By Blog Staff On Tuesday, the Federal Circuit sustained an injunction preventing generic drug maker Apotex, Inc. from selling a similar version of Amgen Inc's Neulasta drug without a 180 day notice period after being approved by the FDA. [read post]
28 Jun 2016, 6:41 am
Amgen (BPCIA patent dance). [read post]
21 Jun 2016, 1:38 pm
Amgen Inc., et al., No. 15-1039 (petition for writ of ceritorari filed February 16, 2016; 4 briefs filed in support); and Amgen Inc., et al. v. [read post]
20 Jun 2016, 10:20 am
SW General Inc. [read post]
3 Jun 2016, 6:40 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
19 May 2016, 8:56 pm
Amgen Inc. et al. v. [read post]
19 May 2016, 7:33 pm
Amgen, Inc., 475 F.3d 1256, 1263 (Fed. [read post]
18 May 2016, 8:19 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
6 May 2016, 12:30 pm
See Centocor, Inc. v. [read post]
